This inventor holds 2 USPTO granted patents. Top assignees: Vsesojuzny Nauchno-Issledovatelsky Institut Genetiki, Other. Active years: 1987-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 834,570 Years Active: 1987-1991
Title: Viktor E Sterkin: Innovator in Biotechnology
Introduction
Viktor E Sterkin is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing human leukocyte interferon alpha-2. With a total of 2 patents, Sterkin's work has had a notable impact on medical research and applications.
Latest Patents
Sterkin's latest patents include a recombinant plasmid DNA pVN 22, which codes for the biosynthesis of human leukocyte interferon alpha-2. This innovative method involves submerged cultivation of a producer strain, specifically Pseudomonas species VG-84, which carries a plasmid pVG3 with an inserted gene for human leukocyte interferon alpha-2. The strain is deposited in the collection of microorganism cultures at the USSR Antibiotics Research Institute under Reg. No. 1742. The cultivation process occurs in a nutrient medium containing sources of carbon and nitrogen, mineral salts, and growth stimulants, under aeration and in the presence of antibiotics such as streptomycin or tetracycline. This method is followed by the isolation and purification of the end product.
Career Highlights
Throughout his career, Viktor E Sterkin has worked with various research institutions, including the All-Union Research Institute of Genetics. His work has been instrumental in advancing the understanding and production of interferon, which plays a crucial role in the immune response.
Collaborations
Sterkin has collaborated with notable colleagues such as Jury Dmitrievich Tsygankov and Andrei J Chistoserdov. Their combined expertise has contributed to the success of their research endeavors.
Conclusion
Viktor E Sterkin's contributions to biotechnology, particularly in the production of human leukocyte interferon alpha-2, highlight his innovative spirit and dedication to advancing medical science. His patents and collaborations reflect a commitment to improving health outcomes through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile